Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Rowlett

Showing results (141-150 of 161) with videos related to

Pageof 17
Sort By:
Alcohol (Fayetteville, N.Y.)|August 30, 2017
Persistent negative effects of alcohol drinking on aspects of novelty-directed behavior in male rhesus macaquesCassie M Chandler, Meagan E Follett, Nicholas J Porter, et al.
Translational Psychiatry|November 21, 2025
Preclinical evidence for a novel pharmacotherapeutic approach for treating benzodiazepine addictionLais F Berro, Jemma E Cook, Eliseu C Moreira-Junior, et al.
Neuropharmacology|October 27, 2009
Discriminative stimulus effects of L-838,417 (7-tert-butyl-3-(2,5-difluoro-phenyl)-6-(2-methyl-2H-[1,2,4]triazol-3-ylmethoxy)-[1,2,4]triazolo[4,3-b]pyridazine): role of GABA(A) receptor subtypesStephanie C Licata, Donna M Platt, Daniela Rüedi-Bettschen, et al.
Journal of Psychopharmacology (Oxford, England)|November 1, 2019
Evaluation of the anti-conflict, reinforcing, and sedative effects of YT-III-31, a ligand functionally selective for α3 subunit-containing GABA<sub>A</sub> receptorsZhiqiang Meng, Lais F Berro, Eileen K Sawyer, et al.
Journal of Psychopharmacology (Oxford, England)|June 20, 2025
Ethanol-induced rapid eye movement sleep suppression in rats: Comparison with subtype-selective GABA<sub>A</sub> receptor compoundsJaren A Reeves-Darby, Lais F Berro, Heather L Hembree, et al.
Frontiers in Pharmacology|May 7, 2021
8-Substituted Triazolobenzodiazepines: <i>In Vitro</i> and <i>In Vivo</i> Pharmacology in Relation to Structural Docking at the α1 Subunit-Containing GABA<sub>A</sub> ReceptorLalit K Golani, Donna M Platt, Daniela Rüedi-Bettschen, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 11, 2013
Reinforcing effects of compounds lacking intrinsic efficacy at α1 subunit-containing GABAA receptor subtypes in midazolam- but not cocaine-experienced rhesus monkeysNina M Shinday, Eileen K Sawyer, Bradford D Fischer, et al.
Alcoholism, Clinical and Experimental Research|March 13, 2019
GABA<sub>A</sub> Receptor Subtypes and the Abuse-Related Effects of Ethanol in Rhesus Monkeys: Experiments with Selective Positive Allosteric ModulatorsLais F Berro, Daniela Rüedi-Bettschen, Jemma E Cook, et al.
Pharmacology, Biochemistry, and Behavior|September 21, 2021
Sleep, psychiatric and socioeconomic factors associated with substance use in a large population sample: A cross-sectional studyVinícius Dokkedal-Silva, Guilherme L Fernandes, Priscila K Morelhão, et al.
Neuropharmacology|May 16, 2024
Assessment of the antinociceptive, respiratory-depressant, and reinforcing effects of the low pK<sub>a</sub> fluorinated fentanyl analogs, FF3 and NFEPPShelley R Edwards, Bruce E Blough, Kristian Cowart, et al.
Pageof 17

Showing results (141-150 of 161) with videos related to

Sort By:
Pageof 17
Alcohol (Fayetteville, N.Y.)|August 30, 2017
Persistent negative effects of alcohol drinking on aspects of novelty-directed behavior in male rhesus macaquesCassie M Chandler, Meagan E Follett, Nicholas J Porter, et al.
Translational Psychiatry|November 21, 2025
Preclinical evidence for a novel pharmacotherapeutic approach for treating benzodiazepine addictionLais F Berro, Jemma E Cook, Eliseu C Moreira-Junior, et al.
Neuropharmacology|October 27, 2009
Discriminative stimulus effects of L-838,417 (7-tert-butyl-3-(2,5-difluoro-phenyl)-6-(2-methyl-2H-[1,2,4]triazol-3-ylmethoxy)-[1,2,4]triazolo[4,3-b]pyridazine): role of GABA(A) receptor subtypesStephanie C Licata, Donna M Platt, Daniela Rüedi-Bettschen, et al.
Journal of Psychopharmacology (Oxford, England)|November 1, 2019
Evaluation of the anti-conflict, reinforcing, and sedative effects of YT-III-31, a ligand functionally selective for α3 subunit-containing GABA<sub>A</sub> receptorsZhiqiang Meng, Lais F Berro, Eileen K Sawyer, et al.
Journal of Psychopharmacology (Oxford, England)|June 20, 2025
Ethanol-induced rapid eye movement sleep suppression in rats: Comparison with subtype-selective GABA<sub>A</sub> receptor compoundsJaren A Reeves-Darby, Lais F Berro, Heather L Hembree, et al.
Frontiers in Pharmacology|May 7, 2021
8-Substituted Triazolobenzodiazepines: <i>In Vitro</i> and <i>In Vivo</i> Pharmacology in Relation to Structural Docking at the α1 Subunit-Containing GABA<sub>A</sub> ReceptorLalit K Golani, Donna M Platt, Daniela Rüedi-Bettschen, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 11, 2013
Reinforcing effects of compounds lacking intrinsic efficacy at α1 subunit-containing GABAA receptor subtypes in midazolam- but not cocaine-experienced rhesus monkeysNina M Shinday, Eileen K Sawyer, Bradford D Fischer, et al.
Alcoholism, Clinical and Experimental Research|March 13, 2019
GABA<sub>A</sub> Receptor Subtypes and the Abuse-Related Effects of Ethanol in Rhesus Monkeys: Experiments with Selective Positive Allosteric ModulatorsLais F Berro, Daniela Rüedi-Bettschen, Jemma E Cook, et al.
Pharmacology, Biochemistry, and Behavior|September 21, 2021
Sleep, psychiatric and socioeconomic factors associated with substance use in a large population sample: A cross-sectional studyVinícius Dokkedal-Silva, Guilherme L Fernandes, Priscila K Morelhão, et al.
Neuropharmacology|May 16, 2024
Assessment of the antinociceptive, respiratory-depressant, and reinforcing effects of the low pK<sub>a</sub> fluorinated fentanyl analogs, FF3 and NFEPPShelley R Edwards, Bruce E Blough, Kristian Cowart, et al.
Pageof 17